Gemma Currie

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

John R. Petrie, Nish Chaturvedi, Ian Ford et al. · The Lancet Diabetes & Endocrinology · 2017 · 347 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

Morten Lindhardt, Frederik Persson, Gemma Currie et al. · BMJ Open · 2016 · 122 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Effect of Fenofibrate on Progression of Diabetic Retinopathy

David Preiss, Jennifer Logue, Emily Sammons et al. · NEJM Evidence · 2024 · 80 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria

Gemma Currie, Bernt Johan von Scholten, Sheon Mary et al. · Cardiovascular Diabetology · 2018 · 49 citations · Full text

Medicine, Internal Medicine, Nephrology +17